• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Src 通过 Hippo 信号通路促进肝细胞癌的生长和肿瘤发生。

c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.

机构信息

Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, China.

Department of Ultrasound, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, China.

出版信息

Life Sci. 2021 Jan 1;264:118711. doi: 10.1016/j.lfs.2020.118711. Epub 2020 Nov 10.

DOI:10.1016/j.lfs.2020.118711
PMID:33186566
Abstract

We investigated the association between c-Src and the progression of hepatocellular carcinoma (HCC) and its underlying mechanisms. The relationship between c-Src expression and the occurrence and development of HCC was explored using GEPIA and further confirmed by western blotting analysis and real-time quantitative PCR. CCK-8, flow cytometry, Transwell, and wound-healing assays were conducted to analyze the effects of c-Src on the growth, cell cycle, apoptosis, migration, and infiltration of HCC cells. Mouse models of transplanted xenogeneic human tumors were constructed to explore the effects of c-Src on HCC tumor growth. Compared with that in adjacent normal liver tissues, the expression level of c-Src in HCC tissues was significantly increased and was negatively correlated with patient survival. These findings are consistent with those in the GEPIA database. Downregulation of c-Src expression can inhibit the growth, infiltration, and migration of HCC cells. c-Src impeded the translocation of YAP from the nucleus to the cytoplasm and promoted Yes-associated protein transcriptional activity. In vivo experiments showed that c-Src inhibition suppressed tumor growth in mice. We found that c-Src can promote the growth and tumorigenesis of HCC cells by activating the Hippo signaling pathway.

摘要

我们研究了 c-Src 与肝细胞癌 (HCC) 进展的关系及其潜在机制。使用 GEPIA 探讨了 c-Src 表达与 HCC 发生和发展的关系,并通过 Western blot 分析和实时定量 PCR 进一步证实。通过 CCK-8、流式细胞术、Transwell 和划痕愈合实验分析了 c-Src 对 HCC 细胞生长、细胞周期、凋亡、迁移和浸润的影响。构建了移植异种人肿瘤的小鼠模型,以探讨 c-Src 对 HCC 肿瘤生长的影响。与相邻正常肝组织相比,HCC 组织中 c-Src 的表达水平显著升高,与患者的生存呈负相关。这些发现与 GEPIA 数据库中的结果一致。下调 c-Src 的表达可以抑制 HCC 细胞的生长、浸润和迁移。c-Src 阻止 YAP 从细胞核向细胞质易位,并促进 Yes 相关蛋白转录活性。体内实验表明,c-Src 抑制可抑制小鼠肿瘤生长。我们发现 c-Src 通过激活 Hippo 信号通路促进 HCC 细胞的生长和肿瘤发生。

相似文献

1
c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.c-Src 通过 Hippo 信号通路促进肝细胞癌的生长和肿瘤发生。
Life Sci. 2021 Jan 1;264:118711. doi: 10.1016/j.lfs.2020.118711. Epub 2020 Nov 10.
2
SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.SEPT6 通过 Hippo/YAP 信号通路驱动肝癌细胞增殖、迁移和侵袭。
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5205. Epub 2021 Apr 13.
3
Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway.SSR2 的下调通过 Hippo 通路增强肝癌对顺铂的敏感性。
Front Biosci (Landmark Ed). 2024 Aug 21;29(8):299. doi: 10.31083/j.fbl2908299.
4
Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.吴茱萸碱通过 Hippo-Yes 相关蛋白信号通路抑制肝癌细胞增殖并促进其凋亡。
Life Sci. 2020 Jun 15;251:117424. doi: 10.1016/j.lfs.2020.117424. Epub 2020 Feb 11.
5
Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.血小板衍生生长因子-BB 通过调节 Hippo/Yes 相关蛋白信号通路介导胰腺癌恶性进展。
Oncol Rep. 2021 Jan;45(1):83-94. doi: 10.3892/or.2020.7859. Epub 2020 Nov 19.
6
MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.微小 RNA-98-5p 通过靶向核因子-κB 诱导激酶抑制乙型肝炎病毒相关肝细胞癌的发生。
Yonsei Med J. 2020 Jun;61(6):460-470. doi: 10.3349/ymj.2020.61.6.460.
7
LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.长链非编码 RNA DBH-AS1 通过 FAK/Src/ERK 通路靶向 miR-138 促进肝癌的发生。
Biomed Pharmacother. 2018 Nov;107:824-833. doi: 10.1016/j.biopha.2018.08.079. Epub 2018 Aug 22.
8
TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.TAZ 靶基因 ITGAV 调控肝癌细胞的侵袭,并正向反馈于 YAP 和 TAZ。
Cancer Lett. 2020 Mar 31;473:164-175. doi: 10.1016/j.canlet.2019.12.044. Epub 2020 Jan 3.
9
LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.LMO3 通过与 LATS1 直接相互作用并抑制 Hippo 信号通路促进肝细胞癌侵袭、转移和抗失巢凋亡。
J Exp Clin Cancer Res. 2018 Sep 15;37(1):228. doi: 10.1186/s13046-018-0903-3.
10
Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.Rac GTPase 激活蛋白 1 的过表达通过减少 Hippo 信号传导促进细胞有丝分裂,从而促进癌细胞的增殖。
Gastroenterology. 2018 Oct;155(4):1233-1249.e22. doi: 10.1053/j.gastro.2018.07.010. Epub 2018 Sep 5.

引用本文的文献

1
Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells.Src家族激酶与索拉非尼的双重抑制增强肝癌细胞的抗肿瘤活性。
Int J Mol Sci. 2025 Jul 6;26(13):6506. doi: 10.3390/ijms26136506.
2
N6-Methyladenosine Promotes the Transcription of c-Src Kinase via IRF1 to Facilitate the Proliferation of Liver Cancer.N6-甲基腺苷通过IRF1促进c-Src激酶转录以促进肝癌增殖。
Oncol Res. 2025 Jun 26;33(7):1679-1693. doi: 10.32604/or.2025.062747. eCollection 2025.
3
CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer.
CRKL 通过与 JNK/JUN 通路的结合及激活增强肝癌中的 YAP 信号。
Int J Mol Sci. 2024 Aug 5;25(15):8549. doi: 10.3390/ijms25158549.
4
Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments.通过网络药理学和细胞实验探索芦荟大黄素治疗肝癌的机制。
Front Pharmacol. 2023 Oct 12;14:1238841. doi: 10.3389/fphar.2023.1238841. eCollection 2023.
5
Hepatocellular Carcinoma: Up-regulated Circular RNAs Which Mediate Efficacy in Preclinical Models.肝细胞癌:上调的环状 RNA 可调节临床前模型的疗效。
Cancer Genomics Proteomics. 2023 Nov-Dec;20(6):500-521. doi: 10.21873/cgp.20401.
6
Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.Hippo-YAP/TAZ 信号通路在肝细胞癌中的复杂作用。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15311-15322. doi: 10.1007/s00432-023-05272-2. Epub 2023 Aug 22.
7
Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.炎症性肠病增加肝胆胰腺肿瘤风险:欧洲和东亚人群两样本孟德尔随机化分析。
Cancer Med. 2023 Jun;12(12):13599-13609. doi: 10.1002/cam4.6057. Epub 2023 May 15.
8
ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.膜联蛋白 A10 是一种预后生物标志物和肝细胞癌的抑制剂:生物信息学分析和实验验证。
Sci Rep. 2023 Jan 28;13(1):1583. doi: 10.1038/s41598-023-28527-x.
9
Study on the molecular mechanism of anti-liver cancer effect of Evodiae fructus by network pharmacology and QSAR model.基于网络药理学和QSAR模型的吴茱萸抗肝癌作用分子机制研究
Front Chem. 2023 Jan 9;10:1060500. doi: 10.3389/fchem.2022.1060500. eCollection 2022.
10
Dissecting the molecular mechanism of cepharanthine against COVID-19, based on a network pharmacology strategy combined with RNA-sequencing analysis, molecular docking, and molecular dynamics simulation.基于网络药理学策略结合 RNA 测序分析、分子对接和分子动力学模拟,剖析莲心碱抗 COVID-19 的分子机制。
Comput Biol Med. 2022 Dec;151(Pt A):106298. doi: 10.1016/j.compbiomed.2022.106298. Epub 2022 Nov 11.